What can light scattering spectroscopy do for membrane-active peptide studies?
about
Membrane binding mode of intrinsically disordered cytoplasmic domains of T cell receptor signaling subunits depends on lipid composition.rBPI(21) promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes.Variations on fibrinogen-erythrocyte interactions during cell aging.Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriersNovel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach.Using zeta-potential measurements to quantify peptide partition to lipid membranes.The effects of interfacial potential on antimicrobial propensity of ZnO nanoparticle.Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.Novel haemoglobin-derived antimicrobial peptides from chicken (Gallus gallus) blood: purification, structural aspects and biological activity.Anticancer peptide SVS-1: efficacy precedes membrane neutralizationMechanism of brain targeting by dexibuprofen prodrugs modified with ethanolamine-related structures.The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif.Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action.Peptides as models for the structure and function of viral capsid proteins: Insights on dengue virus capsid.Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems.Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepRTranslocating the blood-brain barrier using electrostatics.Biophysical characterization of polymyxin B interaction with LPS aggregates and membrane model systems.Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.Correlation between membrane translocation and analgesic efficacy in kyotorphin derivatives.Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom.Engineering of a linear inactive analog of human β-defensin 4 to generate peptides with potent antimicrobial activity.The antimicrobial activity of Sub3 is dependent on membrane binding and cell-penetrating ability.Application of Light Scattering Techniques to Nanoparticle Characterization and Development.Methods for Lipid Droplet Biophysical Characterization in InfectionsControlled adsorption of cytochrome c to nanostructured gold surfacesMembrane Active Peptides and Their Biophysical CharacterizationThe Application of Biophysical Techniques to Study Antimicrobial Peptides
P2860
Q33347799-022BBB25-D568-4AEA-AF41-04DA9977EC8FQ33520240-BB83BA12-9E17-4E3D-BEA4-078CB7E6BCB0Q33862502-14AB932F-C2E9-46D4-8191-017E84AE082FQ33982639-2CFDEFE9-8656-4871-9559-FE7C25C54DE8Q34696447-2D3C9E9F-3043-4511-930F-3909758EEF62Q34757014-1B468851-45C0-4E03-BD1C-AC5D13934B22Q35426724-3A4E07D5-0190-4F91-97F4-BA5A7F7A6D7DQ35794648-356A3A23-713B-4487-A5B1-D10F5AE37F46Q36119903-6D741DD1-A70F-4AC5-AFAE-A927C2767521Q36250016-5DC9E363-0E56-4DD3-9959-672CE63A6C70Q36350484-6B956D91-3C66-4E62-B3E6-8433E6AB813EQ39377315-32622517-DB24-49D9-A41D-A2788A37E318Q40226827-F4F858F7-A9F0-47C5-B99E-DB4A29DE40DAQ40240817-44804E81-DD2D-4976-9965-FBB9233F47A5Q40260826-8FAD29F5-E2D1-452C-8204-475D5A770963Q40355921-7ACC827A-1DE6-495A-93FF-4B6FAB1D0C66Q42092191-DD6CC1DC-2CAA-4DF2-8FFB-BBCF784DF3A3Q43534218-70BC4EDF-406E-4DCD-8FCE-A65C857A4DCCQ46881407-1B55BA66-F914-46DE-8989-CB869B7CF3D2Q48468506-3A59505A-CBBA-4CA7-880B-A8F87A09EC3FQ49644926-C82F0FAD-E614-4350-B350-8D107F08E4A2Q53281868-9B9D409B-CDE2-4D9C-BC2D-56FBF301E174Q54303879-F19E5273-C564-4562-8606-D4CB4665C5F2Q55516366-F49E8B8D-733F-4365-9306-3CDEC6E30338Q57015945-134870DE-D7F6-499D-8C8B-960643A34E46Q57080720-3E955DEB-BB0A-4EE0-A17D-25CCC892B652Q58717273-6D6C2C2E-7BD4-4020-A8C8-120F624AFF32Q58911185-CBBCD555-1080-48FC-BEBF-1AFE0CC5C292
P2860
What can light scattering spectroscopy do for membrane-active peptide studies?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
What can light scattering spectroscopy do for membrane-active peptide studies?
@en
What can light scattering spectroscopy do for membrane-active peptide studies?
@nl
type
label
What can light scattering spectroscopy do for membrane-active peptide studies?
@en
What can light scattering spectroscopy do for membrane-active peptide studies?
@nl
prefLabel
What can light scattering spectroscopy do for membrane-active peptide studies?
@en
What can light scattering spectroscopy do for membrane-active peptide studies?
@nl
P356
P1476
What can light scattering spectroscopy do for membrane-active peptide studies?
@en
P2093
Miguel A R B Castanho
Patrícia S Santiago
P304
P356
10.1002/PSC.1007
P577
2008-04-01T00:00:00Z